Skip to content

Clinical and Radiographic Assessment After Surgical Treatment of Anterior Shoulder Dislocation

Evaluation of Clinical and Radiographic Results After Surgical Treatment With Implant-free Allograft for Anterior Shoulder Dislocation: Pilot Study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04520087
Enrollment
20
Registered
2020-08-20
Start date
2020-10-13
Completion date
2026-05-04
Last updated
2026-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anterior Shoulder Dislocation, Bone Defects, Shoulder Instability

Keywords

Implant-Free Shoulder Instability, Bone Grafting, Shoulder Instability, Glenoid, allograft

Brief summary

The purpose of this study is to evaluate the clinical and radiographic results after surgical treatment with implant-free allograft in the treatment of Anterior Shoulder Dislocation and to assess the safety of the surgery.

Detailed description

Patients will be informed about the study and potential risks. All patients giving written informed consent will undergo a screening visit to assess the eligibility criteria. Patients who meet the eligibility requirements will perform a pre-treatment visit in order to assess their healthy state. Also, patients will undergo to the radiographic visit (RX and TX) as request by clinical practice. All the patients will be treated with arthrotomy mini-open technique with bone allograft at the site of the shoulder lesion. After surgery all the patients will be followed up to 24 months through clinical and radiographic visits.

Interventions

PROCEDUREallograft fixation

Patients with anteroinferior shoulder instability will be clinically treated with a mini-open arthrotomic technique involving the fixation of the corticospongeous bone graft on the glena.

Sponsors

Istituto Ortopedico Rizzoli
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

pilot study

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* antero.inferior shoulder instability with bone loss

Exclusion criteria

* Patients incapable of understanding or wanting; * Patients suffering from: rheumatic diseases, diabetes, infectious processes, congenital ligament laxity, epilepsy, severe osteoporosis.

Design outcomes

Primary

MeasureTime frameDescription
Change from Baseline in DASH score at 24th months24 monthsThe Disabilities of the Arm, Shoulder and Hand (DASH) Score is a 30-item self-reported questionnaire in which the response options are presented as 5-point Likert scales. Scores range from 0 (no disability) to 100 (most severe disability). This score was designed be useful in patients with any musculoskeletal disorder of the upper limb.

Secondary

MeasureTime frameDescription
Change from baseline in DASH scoreBaseline, 1, 3, 6, and 12 monthsThe Disabilities of the Arm, Shoulder and Hand (DASH) Score is a 30-item self-reported questionnaire in which the response options are presented as 5-point Likert scales. Scores range from 0 (no disability) to 100 (most severe disability). This score was designed be useful in patients with any musculoskeletal disorder of the upper limb.
Change from Baseline in Constant scoreBaseline, 1, 3, 6, 12 and 24 monthsThe Constant score contains both physician-completed and patient-reported portions. The four domains include pain (15 possible points), activities of daily living (20 possible points), mobility (40 possible points), and strength (25 possible points). Scores range from 0 points (most disability) to 100 points (least disability).
Change from Baseline in Rowe scoreBaseline, 1, 3, 6, 12 and 24 monthsThe Rowe score is a 3-item physician completed instrument. Its questions address the categories of shoulder stability, motion, and function. Scores range from 0 to 100 with a score of 90-100 points indicating an excellent evaluation, 75-89 points indicating a good evaluation, 51-74 points indicating a fair evaluation, and 0-50 points indicating a poor evaluation.
Change from Baseline in EQ-5D-3L (EuroQoL) CurrentHealthAssessment:Baseline, 1, 3, 6, 12 and 24 monthsEQ-5D is a standardized instrument for measuring generic health status. The classification system defines health in five dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression), each dimension with three levels ("no problems" \[level 1\], "some problems" \[level 2\], and "extreme problems" \[level 3\]), resulting in a total of 243 (3\^5) health states. The 3L classification system defined the 243 health states by combining different levels from each dimension, with 11111 and 33333 representing full health and worst health, respectively.
Evaluation of the grade of the Shoulder Osteoarthritis through Kellgren-Lawrence scoring24 monthsThe Kellgren and Lawrence system is a common method of classifying the severity of osteoarthritis (OA). The K-L system defines OA in 5 grades: grade 0 (none): definite absence of x-ray changes of osteoarthritis grade 1 (doubtful): doubtful joint space narrowing and possible osteophytic lipping grade 2 (minimal): definite osteophytes and possible joint space narrowing grade 3 (moderate): moderate multiple osteophytes, definite narrowing of joint space and some sclerosis and possible deformity of bone ends grade 4 (severe): large osteophytes, marked narrowing of joint space, severe sclerosis and definite deformity of bone ends.
Evaluation of the Allograft integration6 and 12 monthsRadiographic signs of allograft integration through the CT-dual energy instrument at 6 and 24 month post treatment

Countries

Italy

Contacts

PRINCIPAL_INVESTIGATOREnrico Guerra, MD

Istituto Ortopedico Rizzoli

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 23, 2026